Fiasp®▼ (Novo Nordisk) is a newly licensed formulation of insulin aspart with a more rapid onset of action than NovoRapid. The active substance is identical to that in NovoRapid; however nicotinamide (vitamin B3) has been added to allow faster insulin absorption.
New Generic codes have been created for the Fiasp products and they have been removed from the existing Generic codes:
